tiprankstipranks
Advertisement
Advertisement

XGN Stock Latest News

Roth starts Exagen at Buy, notes biomarker testing outperformance
The FlyRoth starts Exagen at Buy, notes biomarker testing outperformance
27d ago
XGN
Exagen initiated with a Buy at Roth Capital
PremiumThe Fly
Exagen initiated with a Buy at Roth Capital
27d ago
XGN
Exagen Shareholders Approve Directors, Auditor and Pay Package
PremiumCompany Announcements
Exagen Shareholders Approve Directors, Auditor and Pay Package
1M ago
8K
XGN
Exagen Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
Exagen Earnings Call Highlights Growth Amid Headwinds
2M ago
XGN
Exagen Earnings Call Highlights Growth Amid Key Risks
PremiumCompany Announcements
Exagen Earnings Call Highlights Growth Amid Key Risks
2M ago
XGN
Exagen Wins Buy Rating on Strong Q1 Beat, Improving Fundamentals and Clear Path to EBITDA Breakeven
PremiumRatingsExagen Wins Buy Rating on Strong Q1 Beat, Improving Fundamentals and Clear Path to EBITDA Breakeven
2M ago
XGN
Exagen: Buy Rating Reiterated as Strong Execution and Growth Outlook Support Unchanged $8 Price Target
Premium
Ratings
Exagen: Buy Rating Reiterated as Strong Execution and Growth Outlook Support Unchanged $8 Price Target
2M ago
XGN
Exagen price target lowered to $8 from $9 at BTIG
Premium
The Fly
Exagen price target lowered to $8 from $9 at BTIG
2M ago
XGN
Exagen’s Risk Profile Remains Unchanged: Stable Yet Persistent Exposures Keep Investors on Alert
PremiumCompany Announcements
Exagen’s Risk Profile Remains Unchanged: Stable Yet Persistent Exposures Keep Investors on Alert
2M ago
XGN
Exagen reports Q1 EPS (17c), consensus (25c)
PremiumThe Fly
Exagen reports Q1 EPS (17c), consensus (25c)
2M ago
XGN
Exagen backs FY26 revenue view $70M-$73M, consensus $71.27M
PremiumThe Fly
Exagen backs FY26 revenue view $70M-$73M, consensus $71.27M
2M ago
XGN
XGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
XGN Earnings this Week: How Will it Perform?
2M ago
XGN
Exagen Announces Board Resignation and Committee Restructuring
PremiumCompany AnnouncementsExagen Announces Board Resignation and Committee Restructuring
3M ago
8K
XGN
Exagen price target lowered to $8 from $10 at Canaccord
Premium
The Fly
Exagen price target lowered to $8 from $10 at Canaccord
3M ago
XGN
Exagen price target lowered to $10 from $12 at Craig-Hallum
Premium
The Fly
Exagen price target lowered to $10 from $12 at Craig-Hallum
4M ago
XGN
Exagen price target lowered to $10 from $15 at Canaccord
PremiumThe Fly
Exagen price target lowered to $10 from $15 at Canaccord
4M ago
XGN
Exagen price target lowered to $10 from $15 at KeyBanc
PremiumThe Fly
Exagen price target lowered to $10 from $15 at KeyBanc
4M ago
XGN
Exagen price target lowered to $9 from $10 at BTIG
PremiumThe Fly
Exagen price target lowered to $9 from $10 at BTIG
4M ago
XGN
Maintaining a Buy: Conservative Guidance but Solid Demand and Pipeline Support Long-Term Upside
PremiumRatings
Maintaining a Buy: Conservative Guidance but Solid Demand and Pipeline Support Long-Term Upside
4M ago
XGN
Exagen reports Q4 EPS (20c), consensus (19c)
PremiumThe FlyExagen reports Q4 EPS (20c), consensus (19c)
4M ago
XGN
Exagen sees FY26 revenue $70M-$73M, consensus $73.84M
Premium
The Fly
Exagen sees FY26 revenue $70M-$73M, consensus $73.84M
4M ago
XGN
Is XGN a Buy, Before Earnings?
Premium
Pre-Earnings
Is XGN a Buy, Before Earnings?
5M ago
XGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >